Serial FES PET/CT to Measure Hormone Expression in Patients Undergoing Endocrine Targeted Therapy

Clinical trial NCT04692103 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04692103
Sponsor: University of Washington
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Estrogen Receptor Positive Primary or Recurrent Breast Carcinoma Stage IV Breast Cancer AJCC v6 and v7

Start date: 2021-07-10
Primary completion: 2021-10-01
Enrollment: 2

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.